Exploring how natural products are made to improve their use in medicine
Biosynthesis of unusual bio-orthogonal functionalities in natural products
This study is looking at how certain natural substances are made and how we can improve them to create better medicines, which could help patients with various diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-10653015 on NIH RePORTER |
What this research studies
This research investigates the biosynthesis of unique functional groups in natural products, which are essential for their biological activities. By understanding the enzymes involved in creating these functionalities, the project aims to enhance or modify the effectiveness of these compounds for therapeutic purposes. The research focuses on specific enzymes that produce unusual pharmacophores, such as terminal alkynes and isonitriles, which could lead to new applications in treating diseases. Patients may benefit from advancements in drug development stemming from this work.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with conditions that could be treated by novel natural product-derived therapies.
Not a fit: Patients with conditions that are not addressed by natural products or those who do not respond to such therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments for various diseases through improved natural products.
How similar studies have performed: Other research has shown success in enhancing natural products through biosynthetic manipulation, indicating a promising approach.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Zhang, Wenjun — University of California Berkeley
- Study coordinator: Zhang, Wenjun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.